Q4 2024 Earnings Call Transcript May 22, 2025 Operator: Good morning and welcome to the AMSC Fourth Quarter Fiscal 2024 ...

AstraZeneca’s biologics division MedImmune is to spin out a new standalone biotech to develop six early-stage inflammation and autoimmunity programmes. To be known as Viela Bio, the spin-out ...

Drugmaker AstraZeneca has teamed up with Indian digital health specialist Qure.ai and a clinical group in the UK to test an artificial intelligence-powered technology to help radiologists ...